EUVIMEDEUVIMED entdecken
Open Access

Polymer Lung Surfactants Attenuate Direct Lung Injury in Mice

Daniel J Fesenmeier, Madathilparambil V Suresh, Seyoung Kim, Sungwan Park, Krishnan Raghavendran, You-Yeon Won iD

ACS Biomaterials Science & Engineering · 2023

DOI: 10.1021/acsbiomaterials.3c00061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2023. Verfasst von Daniel J Fesenmeier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana 47907, United States. Hauptthemen laut MEDLINE: Pulmonary Surfactants, Respiratory Distress Syndrome, Acute Lung Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Division of Industrial Innovation and Partnerships.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

If not properly managed, acute lung injuries, either through direct or indirect causes, have the potential to present serious risk for many patients worldwide. One of the mechanisms for the transition from acute lung injury (ALI) to the more serious acute respiratory distress syndrome (ARDS) is the deactivation of the native lung surfactant by injury-induced infiltrates to the alveolar space. Currently, there are no surfactant replacement therapies that are used to treat ALI and subsequent ARDS. In this paper, we present an indepth efficacy study of using a novel polymer lung surfactant (PLS, composed of poly(styrene-block-ethylene glycol) (PS-PEG) block copolymer micelles), which has unique properties compared to other tested surfactant replacements, in two different mouse models of lung injury. The results demonstrate that pharyngeal administration of PLS after the instillation of either acid (HCl) or lipopolysaccharide (LPS) can decrease the severity of lung injury as measured by multiple injury markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary SurfactantsRespiratory Distress SyndromeAcute Lung InjuryMiceAnimalsPolymersLungEthylene Glycols

Stichwörter der Autor:innen

acute lung injuryacute respiratory distress syndromeblock copolymer micellepolymer lung surfactantsurfactant replacement therapy

Substanzen

PolymersPulmonary Surfactantsstyrene glycolEthylene Glycols

Autor:innen und Institutionen

  • Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.
  • Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.
  • Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.

ORCID-Profile: You-Yeon Won

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Division of Industrial Innovation and Partnerships
  • Division of Chemical, Bioengineering, Environmental, and Transport Systems
  • Spirrow Therapeutics

Zitieren

APA

Fesenmeier, D. J., Suresh, M. V., Kim, S., Park, S., Raghavendran, K., & Won, Y. Y. (2023). Polymer Lung Surfactants Attenuate Direct Lung Injury in Mice. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.3c00061

Vancouver

Fesenmeier DJ, Suresh MV, Kim S, Park S, Raghavendran K, Won YY. Polymer Lung Surfactants Attenuate Direct Lung Injury in Mice. ACS Biomaterials Science & Engineering. 2023. doi:10.1021/acsbiomaterials.3c00061

BibTeX
@article{Fesenmeier2023,
  author = {Fesenmeier, Daniel J and Suresh, Madathilparambil V and Kim, Seyoung and Park, Sungwan and Raghavendran, Krishnan and Won, You-Yeon},
  title = {Polymer Lung Surfactants Attenuate Direct Lung Injury in Mice},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2023},
  doi = {10.1021/acsbiomaterials.3c00061}
}
Kostenlos starten →